You are here: Industry Insights > Lonza

News List

Lonza, Synpromics Enter Biomanufacturing Partnership contractpharma
May 17, 2019
Lonza, Synpromics Enter Biomanufacturing Partnership.
Chiasma, Lonza Advance Commercial Supply Pact contractpharma
May 16, 2019
Lonza to manufacture MYCAPSSA to support the anticipated launch and ongoing commercial supply.
Lonza Pharma&Biotech Launches Ibex™ Solutions – An Innovative New Concept in Biological Manufacturing and Development europeanpharmaceuticalreview
May 07, 2019
Lonza’s commitment to constant innovation and adding value to its customers and partners is today demonstrated by the launch of Ibex™ Solutions – a unique addition to its current offering…
Lonza plagued by supply problems after China plant explosion fiercepharma
April 21, 2019
An explosion at a chemical plant in China that killed 62 people not only exposed weaknesses in China’s safety oversight but it also exposed weaknesses in the global ingredient supply chain.
Lonza JV to produce live biotherapeutics for gut bacteria field fiercepharma
April 10, 2019
The FDA and the pharma industry have taken note as the nutrition industry has promoted gut bacteria for preventing disease.
'Drugs from bugs' joint venture cphi-online
April 08, 2019
Lonza and Chr. Hansen create a strategic joint venture to become the partner of choice for developing and manufacturing live biotherapeutic products for pharma and biotech customers.
Lonza Announces New Executive Committee Appointment americanpharmaceuticalreview
February 27, 2019
Lonza has announced internal alignment of its business structure along the Healthcare Continuum and strengthen the Microbial Control business.....
Lonza Collaborates with Takeda to Bring Cancer Treatment to Patients americanpharmaceuticalreview
January 14, 2019
Lonza announced another milestone in its multiproduct partnership with Takeda. Takeda Pharmaceutical announced in November 2018 that ....
Lonza to establish new base in China using GE healthcare solution biospectrumasia
December 17, 2018
New biologics facility, scheduled to be operational in 2020, will provide development and manufacturing facilities from early- to late-clinical and early-commercial stages.
Lonza to Establish Strategic Biomanufacturing Base in China Using GE Healthcare Solution americanpharmaceuticalreview
December 11, 2018
Lonza announced an agreement with GE Healthcare under which GE Healthcare will deliver a biologics facility to Lonza in Guangzhou (CN). As the facility is part of a larger....

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 Next page